PPARG has also been suggested as a potential therapeutic target gene for oral squamous cell carcinoma [9], and the activation of PPARG was shown to downregulate several features of the neoplastic phenotype in human upper aerodigestive tract tumors [10]. Here, PPARG is linked to oral cavity squamous cell carcinoma.